CCO Infectious Disease Podcast

Which Patients With Hepatitis B Should We Be Treating?

Episode Summary

Listen as Ira M. Jacobson, MD; Paul Y. Kwo, MD; and Tatyana Kushner, MD, MSCE, discuss guideline recommendations for HBV treatment indications, recent data describing the relationship between viral suppression and HBV DNA integration, and more expansive indications for HBV treatment based on virologic considerations.

Episode Notes

Are we treating HBV early enough? Is it time to move the goalposts regarding the timing of treatment initiation? What are the potential benefits of earlier treatment?

To answer these questions, Ira M. Jacobson, MD, leads a panel discussion with Tatyana Kushner, MD, MSCE, and Paul Y. Kwo, MD, exploring which patients with HBV we should be treating, including a focus on:


Ira M. Jacobson, MD
Professor of Medicine
Director of Hepatology
NYU Langone Health
New York, New York

Tatyana Kushner, MD, MSCE
Associate Professor
Division of Liver Diseases
Icahn School of Medicine at 
Mount Sinai
New York, New York

Paul Y. Kwo, MD
Professor of Medicine 
Director of Hepatology 
Stanford University School of Medicine
Palo Alto, California

Link to the full program:

Link to the slides: